Showing results (1-10 of 600) with videos related to
Sort By:
Pageof 60
Cancer Discovery|September 3, 2017
Spotlight on Ibrutinib in PCNSL: Adding Another Feather to Its CapAparna Lakshmanan, John C ByrdJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Chronic lymphocytic leukemia: state of the art and beyondJohn C ByrdCancer Discovery|July 31, 2015
Mass Cytometry: A High-Throughput Platform to Visualize the Heterogeneity of Acute Myeloid LeukemiaPriscilla Do, John C ByrdBest Practice & Research. Clinical Haematology|July 13, 2010
Signalling to drug resistance in CLLErin Hertlein, John C ByrdCurrent Opinion in Hematology|June 7, 2006
Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemiaAruna Gowda, John C ByrdCancer Cell|June 10, 2015
Antagonizing ClpP: A New Power Play in Targeted Therapy for AMLKarilyn Larkin, John C ByrdCancer Discovery|March 3, 2019
Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLLShanmugapriya Thangavadivel, John C ByrdHormones & Cancer|September 20, 2014
Modulation of sodium iodide symporter in thyroid cancerAparna Lakshmanan, Daniel Scarberry, Daniel H Shen, et al.Seminars in Hematology|March 31, 2010
Rituximab in chronic lymphocytic leukemiaSamantha M Jaglowski, John C ByrdPageof 60